ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2015, Vol. 24 ›› Issue (5): 412-418.

• 论文 • 上一篇    下一篇

血栓性微血管病相关肾脏疾病患者临床病理特点及预后

  

  • 出版日期:2015-10-28 发布日期:2015-10-30

Clinico-pathological characteristics and prognosis in patients with thrombotic microangiopathy

  • Online:2015-10-28 Published:2015-10-30

摘要:

【摘 要】 目的:比较血栓性微血管病(TMA)相关肾脏疾病的临床、肾脏病理特征及其预后。 方法:经肾活检诊断为TMA,选取非典型溶血尿毒综合征(aHUS)(n=38)、狼疮性肾炎相关性TMA(LN-TMA)(n=37)、妊娠相关性TMA(P-TMA)(n=22),比较三组TMA患者的临床、病理特征及预后。 结果:aHUS组患者临床表现最重,表现为血肌酐水平最高(aHUS 791.2 (396.9-1148.3)μmol/L vs. LN-TMA 388.1(189.2-581.7) μmol/L vs. P-TMA 69.8(53.9-556.9) μmol/L),贫血的发生率(aHUS 100% vs. LN-TMA 97.3% vs. P-TMA 63.6%)均高于其他两组,肾脏病理TMA表现多样。P-TMA组病情最轻,肾功能不全(aHUS 100% vs. LN-TMA 89.2% vs. P-TMA 50.0%)、贫血、血小板减少(aHUS 76.3% vs. LN-TMA 75.7% vs. P-TMA 27.3%)发生率显著低于其他两组,病理以肾小球双轨病变(aHUS 55.3% vs. LN-TMA 45.9% vs. P-TMA 95.5%)最为突出。LN-TMA蛋白尿水平(aHUS 1.38(0.74-2.58) g/24h vs. LN-TMA 2.65(1.87-5.33) g/24h vs. P-TMA 1.18(0.68-1.64)g/24h)及镜下血尿(aHUS 65.8% vs. LN-TMA 89.2% vs. P-TMA 50.0%)发生率最高,病理上动脉血栓(aHUS 57.9% vs. LN-TMA 83.8% vs. P-TMA 22.7%)及肾小球血栓(aHUS 26.3% vs. LN-TMA 59.5% vs. P-TMA 4.5%)形成均位列三组之首。随访末aHUS组 预后最差,P-TMA组预后最好(ESRD发生率aHUS 63.2% vs. LN-TMA 24.3% vs. P-TMA 18.2%),LN-TMA肾功能完全恢复比例最高(aHUS 15.8% vs. LN-TMA 27.0% vs. P-TMA 18.2%)。肾小管间质慢性病变与肾脏长期预后独立相关。肾活检病理动脉内膜纤维性增生、球性硬化及肾小管间质慢性病变比例高是肾功能不全不能逆转的危险因素。 结论:TMA相关肾脏疾病临床特点、肾脏病理改变及预后存在显著差异,接受肾活检的三组患者中aHUS预后最差,LN-TMA及P-TMA预后相对较好。 

关键词: 血栓性微血管病, 非典型溶血尿毒综合征, 狼疮性肾炎, 妊娠, 肾脏病理, 预后

Abstract:

ABSTRACT Objective: To compare the clinico-pathological characteristics and prognosis in patients with different types of TMA by proven renal biopsy. Methodology: Ninty seven patients who diagnozed as TMA by renal biopsy were enrolled into this retrospective study. They included atypical hemolytic uremic syndrome (aHUS) (n=38), lupus nephritis-associated TMA (LN-TMA) (n=37), and pregnancy-associated TMA (P-TMA) (n=22). Their clinico-pathological characteristics and the prognoses were compared. Results: The patients with aHUS presented a highest level of serum creatinine 791 (397~1148) μmol/L vs. LN-TMA 388 (189~582) μmol/L vs. P-TMA 69.8 (53.9~557) μmol/L),and a highest incidence of anemia (100% vs. LN-TMA 97.3% vs. P-TMA 63.6%), with a wide variety of TMA lesions. The patients with P-TMA presented the lowest level of systemic involvement, the lowest incidences of renal insufficiency (aHUS 100% vs. LN-TMA 89.2% vs. P-TMA 50.0%), anemia and thrombocytopenia (aHUS 76.3% vs. LN-TMA 75.7% vs. P-TMA 27.3%), and the highest incidence glomerular basement membrane (GBM) reduplication (aHUS 55.3% vs. LN-TMA 45.9% vs. P-TMA 95.5%). However, the patients with LN-TMA presented the highest level of proteinuria (aHUS 1.38 (0.74~2.58)g/24h vs. LN-TMA 2.65 (1.87~5.33) g/24h vs. P-TMA 1.18 (0.68~1.64) g/24h), the highest incidence of microscopic hematuria (aHUS 65.8% vs. LN-TMA 89.2% vs. P-TMA 50.0%), and arterial and glomerular thrombi dominantly (aHUS 57.9% vs. LN-TMA 83.8% vs. P-TMA 22.7%; aHUS 26.3% vs. LN-TMA 59.5% vs. P-TMA 4.5%, respectively). At the end of follow-up, aHUS patients showed the poorest renal outcomes to end-stage renal disease (aHUS 63.2% vs. LN-TMA 24.3% vs. P-TMA 18.2%, P<0.001), whereas LN-TMA patients had the highest incidence of recovery of renal insufficiency (aHUS 15.8% vs. LN-TMA 27.0% vs. P-TMA 18.2%, P<0.001). The percentage of tubular atrophy/interstitial fibrosis (TAIF) independently influenced the renal survival. The presence of arteriolar /arterial intimal fibroplasia, the increased percentages of glomerulosclerosis and TAIF were risk factors for non-recovering from renal insufficiency. Conclusions: The patients with different types of TMA presented a wide variety of clinico-pathological characteristics and prognoses. In these three groups, patients with aHUS had the worst prognoses, whereas patients with LN-TMA and P-TMA had better prognoses.

Key words: thrombotic microangiopathy, atypical hemolytic uremic syndrome, lupus nephritis, pregnancy, renal biopsy, prognosis